Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide

Yilmaz, N.Emmungil, H.Gucenmez, S.Ozen, G.Yildiz, F.Balkarli, A.Kimyon, G.2024-06-122024-06-1220150392-856X1593-098Xhttps://hdl.handle.net/20.500.14551/2677611th International Congress on Systemic Lupus Erythematosus -- SEP 02-06, 2015 -- Vienna, AUSTRIA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamideConference Object333S67S67Q2WOS:000360421900240